Tyler J. Fraum1, Daniel R. Ludwig1, Eric H. Kim2, Paul Schroeder3, Thomas A. Hope4, Joseph E. Ippolito1
Canadian Journal of Urology, Vol.25, No.4, pp. 9371-9383, 2018
Abstract Introduction: In the past, positron emission tomography (PET) has played a relatively limited role in prostate cancer imaging. However, in recent years, several new PET tracers have emerged, offering potential improvements in diagnostic performance for both the detection of prostate cancer metastases at initial staging and the localization of recurrent disease.
Materials and methods: We reviewed the literature for prostate cancer PET tracers that are either being used for patient management or being evaluated in clinical research trials. For each tracer, we compiled clinically relevant background information and evidence supporting clinical use, with the intention of providing… More >